Community Pharmacy England (CPE) - News updates

Community pharmacies received strong backing in Parliament today, with multiple MPs speaking out in support of what pharmacies do for their local communities. MPs welcomed the new funding settlement, but also warned of the economic peril that community pharmacies are still in. The Westminster Hall debate, sponsored by Rachel Gilmour, Liberal Democrat MP for Tiverton [...] The post MPs say “Pharmacy funding must match words” appeared first on Community Pharmacy England.

With the deadline now imminent, Community Pharmacy England is urging pharmacy owners to take action to complete the Data Security and Protection Toolkit (DSPTK) for 2026 now and reminding them to make use of our resources to work through the process as efficiently as possible. The DSPTK submission is due by 30th June 2026 as [...] The post One month to go: Data Security Toolkit completion underway appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (02/06/2026) confirmed the following final list of price concessions for May 2026: Drug Pack size Price concession Atorvastatin 60mg tablets 28 £4.37 Betamethasone 0.1% ear/eye/nose drops 10 £2.82 Bicalutamide 150mg tablets 28 £4.77 Bicalutamide 50mg tablets 28 £2.95 Eplerenone 25mg tablets 28 £2.35 Lisinopril 20mg tablets [...] The post May 2026 Price Concessions Final Update appeared first on Community Pharmacy England.

MHRA Class 2 Medicines Recall: ChloraPrep 2% 1mL and ChloraPrep Frepp 2% 1.5mL applicators (Becton Dickinson UK Ltd) Drug alert number: EL(26)A/26 Date issued: 2 June 2026 Becton Dickinson UK Ltd are recalling batches of ChloraPrep 2% 1mL applicators and ChloraPrep Frepp 2% 1.5 mL applicators due to a potential breach of sterility in the [...] The post MHRA Class 2 Medicines Recall: ChloraPrep 2% 1mL and ChloraPrep Frepp 2% 1.5mL applicators (Becton Dickinson UK Ltd) appeared first on Community Pharmacy England.

Full details of the Pharmacy Quality Scheme (PQS) 2026/27 are now available on our PQS hub page following the announcement on the arrangements for the Community Pharmacy Contractual Framework (CPCF) in 2026/27 on Friday (29th May 2026) and a Drug Tariff Update which was published today (2nd June 2026). View the PQS 2026/27 hub page [...] The post New Pharmacy Quality Scheme for 2026/27 announced appeared first on Community Pharmacy England.

The list of price concessions granted for May 2026 currently includes 219 lines. With a few more lines still being discussed, this already surpasses the number of price concessions granted in the previous two record-breaking months. Third month of record drug price concessions | Chemist+Druggist The continuation of this concerning trend is putting more pressure [...] The post Third month of record price concessions appeared first on Community Pharmacy England.

Following representations from Community Pharmacy England, the Department of Health and Social Care (DHSC) has re-determined that the following products will be granted special container status from 1 June 2026. Generic drug name (dm+d descriptor) Brand and/or manufacturer Pack Size Special container Semaglutide 1.5mg tablets Rybelsus® 1.5mg tablets (Novo Nordisk Ltd) 30 tablet        [...] The post 3 products re-classified as special containers from June 2026 appeared first on Community Pharmacy England.

Announcement Summary Funding to increase by 10.3% (£340m) in 2026/27 to £3.636 billion Government commits to working jointly on programme of reform, which will be critically important to set the future strategy for the sector Margin write-off up to end of 2025/26, and funding uplift includes £200 million to be added to the annual margin [...] The post CPE secures 10% funding rise, but pushes for reform appeared first on Community Pharmacy England.

Update 28/05/26 – The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocol (SSP) for Ramipril 1.25mg capsules (SSP087) was due to expire 29 May 2026 but has been further extended to Friday 24 July 2026. In response to a significant ongoing disruption to the supply of Ramipril [...] The post SSP for Ramipril 1.25mg capsules extended appeared first on Community Pharmacy England.

MHRA Class 2 Medicines Recall: Ramipril 2.5mg capsules (Crescent Pharma Limited) Drug alert number: EL(26)A/25 Date issued: 28 May 2026 Crescent Pharma Limited is initiating a precautionary recall of one batch of Ramipril 2.5 mg Capsules following the identification of a potential packaging error at the manufacturing site. DMRC reference number: DMRC-39617807 Company name: Crescent Pharma [...] The post MHRA Class 2 Medicines Recall: Ramipril 2.5mg capsules (Crescent Pharma Limited) appeared first on Community Pharmacy England.